Our results tend to support these overall findings of reliable remodelling of DBM to new bone. The histological analysis showed significant new bone formation and decreasing residual DBM material in ...
SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health announced today that the first patient has been treated with its newly released OssiGraft™ viable bone matrix (VBM) allograft in an ankle surgery, ...
As previously disclosed, in late Q3 2022, the Company began to experience material supply issues related to its ALLOCYTE ® Advanced Cellular Bone Matrix (“ALLOCYTE”) product line. The supply ...
Osteocytes, the most abundant cells in bone tissue, have long been underestimated in their functional capacity. Traditionally viewed as passive entities, recent research has illuminated their pivotal ...
Molecular Matrix, a privately held company that arose from the University of California, Davis, received FDA approval for its Osteo-P bone graft substitute technology. Osteo-P is a non-mineralized, ...
MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of ...
The narrative around bone health has long been dominated by a singular focus: calcium consumption. Yet despite widespread calcium supplementation, osteoporotic fractures affect approximately one in ...
Nine patients (6 male and 3 female, 30 to 64 years old) that were scheduled for elective removal of dorsal instrumentation hardware over a 12-month time period were included in our study. Indications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback